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Volume 49, Number 5S Poster Presentations 35Swas confirmed on postoperative surveillance. These data demonstrate that
effective and durable aneurysm exclusion is the rule, not the exception, even
in the presence of challenging neck anatomy.
Neck and aneurysm characteristics
Mean Range Incidence
Neck diameter 23.1 mm 16.2 - 41.3 mm N/A
Neck length 15.7 mm 1.5 - 21 mm N/A
Neck Calcification N/A N/A 48%
Neck Thrombus N/A N/A 26%
Suprarenal angle 18.5° 3 - 41° N/A
Infrarenal angle 32.5° 6 - 85° N/A
Reverse cone N/A N/A 33%
Max AAA diameter 53 mm 23 - 100 mm N/A
Author Disclosures: J.L. Grisafi, None; R. Rahbar, None; J. Nelms,
None; B.A. Chess, None; S.C. Muluk, None.
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Midterm Results of the Powerlink Suprarenal Bifurcated Device Piv-
otal Trial
Jeffrey P Carpenter, for the Endologix Investigators. Robert Wood Johnson
Medical School, Camden, NJ
Objective: We assessed the results of abdominal aortic aneurysm
(AAA) repair with the Powerlink suprarenal bifurcated endovascular stent
graft compared with open repair.
Methods: Beginning in October 2001, a prospective, controlled mul-
ticenter trial of the Powerlink suprarenal system for endovascular aneurysm
repair was conducted at 17 sites in a pivotal US Food and Drug Adminis-
tration trial. Supported by a Bayesian predictive probability analysis, test
patient enrollment was discontinued early in November 2007 (N153).
Open AAA control patients were enrolled in the Powerlink infrarenal trial.
Stent grafts were oversized by 10% to 20% relative to computed tomography
scan (CT)-based measurements. All repairs were performed through one
surgically exposed femoral artery and contralateral 9Fr percutaneous access.
Post-operatively, results were assessed with contrast-enhanced CT scans and
abdominal x-rays at 1, 6, and 12 months, and annually to five years.
Results: Technical success was achieved in 98.7% of patients, with two
intraoperative conversions. Clinical utility measures were significantly re-
duced in the Powerlink group compared to the control group (p0.0001)
in terms of blood loss, procedure time, and intensive care unit and hospital
lengths of stay. Within 30 days, fewer Powerlink than control patients died
(1.3% vs. 6.1%, p0.06) or experienced a major adverse event (MAE, 5.2%
vs. 23%, p0.0004). This trend is observed for cumulative events within one
year (mortality: 7.2% vs. 14%, p0.208; MAE: 20% vs. 30%, p0.037). In
the longer term, MAE-free survival was similar between groups (p0.731).
At the one-month CT scan, the core lab reported endoleak in 56 patients, of
which 47 had a Type II endoleak. Through longer-term follow-up (mean 22
months), Type II endoleak predominated, with no Type III or IV endoleak.
Secondary procedures were performed in 23 patients (15%) for treatment of
endoleak (n18), limb obstruction (n3), and other causes (n3). No
ruptures or device material failure has occurred. A progressive reduction in
mean aneurysm sac diameter is observed in follow-up.
Conclusion: The Powerlink suprarenal system appears safe and effec-
tively protects patients from AAA rupture over the intermediate term.
Continued careful follow-up is needed to ensure the durability of these
results.
Author Disclosures: Author Disclosures: J.P. Carpenter, Endologix.
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A Reappraisal of Extent IV Thoracoabdominal Aortic Aneurysms
Ali Azizzadeh, Charles C. Miller, III, Anthony L. Estrera, Sheila M. Coo-
gan, Kristopher Charlton-Ouw, Hazim J. Safi. University of Texas Health
Science Center, Houston, TX
Objective: Extent IV aneurysms have long been viewed as low risk
members of the thoracoabdominal aortic aneurysm (TAAA) family. This
perception is based largely on old data in which extent I and II aneurysms
carried extremely high morbidity (paraplegia / paraparesis) and mortalityrisk relative to extent IV aneurysms. More recently, we have shown that
preoperative renal function as measured by glomerular filtration rate (GFR)
is worse with more extensive abdominal / visceral aortic involvement. Here
we revisit the risk factors and outcomes of open repair of extent IV TAAA.
Methods: Between February 1991 and July 2008, we repaired 231
Crawford extent IV TAAA. Median age of the population was 70 (range
37-86) and 77/231 (33%) patients were female. All repairs were performed
using open technique with graft replacement using distal aortic perfusion
and cerebrospinal fluid drainage.
Results: Median baseline GFR was 59.6 (interquartile range 42-80)
ml/min/1.73m2. When GFR is below the median, 30-day mortality is
30/111 (27%) vs 10/120 (8%), odds ratio 4.1, p 0.0002. Three immedi-
ate neurologic deficits occurred in the population (3/231  1%), and all of
these were in the lowest quartile of GFR (GFR  42).
Conclusions: Mortality following extent IV TAAA repair is strongly
correlated with preoperative GFR. Neurologic deficit rates are very low in
this population (1%) and in our experience occur exclusively in the setting of
very low GFR. Risk stratification based on preoperative GFR is helpful in
evaluating the outcome of different treatment modalities for patients with
extent IV TAAA.
Author Disclosures: A. Azizzadeh, None; C.C. Miller, None; A.L.
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Respiratory Morbidity Following Thoracoabdominal Aortic Repair
Charles C Miller, III, Anthony L Estrera, Ali Azizzadeh, Gasan Noredin,
Daniela Gatenero, Sheila M Coogan, Hazim J Safi. University of Texas
Medical School Houston, Houston, TX
Background: Respiratory morbidity is significant following thoraco-
abdominal aortic aneurysm repair, with a substantial number of patients
requiring mechanical ventilation for more than 3 days postoperatively.
Though frequently reversible, difficulty weaning increases complexity of
hospitalization and mortality. We reviewed our experience with 1443 pa-
tients undergoing descending thoracic or thoracoabdominal aortic repair.
Methods: Between February 1991 and July 2008, we performed 1443
descending thoracic or thoracoabdominal aortic repairs. Median patient age
was 68 (interquartile range 58-74) and 539 (37%) were female. Preoperative
and intraoperative factors were evaluated using multiple logistic regression
analysis.
Results: 432/1443 (30%) patients required mechanical ventilation of
greater than 72 hours’ duration. Significant, independent preoperative risk
factors were FEV1 80% of predicted, decreasing glomerular filtration rate
(GFR), emergency presentation, rupture and chronic obstructive pulmonary
disease (COPD). Increasing aortic crossclamp time was the only intraoper-
ative risk factor. Mortality among patients with prolonged ventilation was
135/432 (31%) vs. 102/999 (10%) without. For patients with normal GFR
and FEV1, mortality is 2.4 percent (p0.0004).
Conclusion: Ventilatory failure following thoracoabdominal aortic
surgery occurs predominantly among the high-risk; specifically those with
poor preoperative pulmonary and renal function and with rupture and
emergent presentation. Long crossclamp times are also contributory. Mor-
tality is significant in these patients.
Author Disclosures: C.C. Miller, None; A.L. Estrera, None; A. Azizza-
deh,None;G. Noredin,None;D. Gatenero,None; S.M. Coogan,None;
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gan, Kourosh Keyhani, Hazim J. Safi. University of Texas Health Science
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Objective: Descending thoracic and thoracoabdominal aortic aneu-
rysms are complex, life threatening problems that present significant man-
agement challenges. As the range of treatment options grows, so too does
the obligation of surgeons to understand and consider risk factors and how
these might affect treatment. We reviewed our experience with open de-
scending thoracic and thoracoabdominal aortic repairs to identify risk factors
for neurologic deficit and mortality in contemporary practice.Methods: Between February 1991 and July 2008, we performed 1443
descending thoracic or thoracoabdominal aortic operations. Median patient
